MDSpire - Takeaway
Feature

Breast Cancer Recurrence Remains Low—Even After 10 Years—With Radiotherapy Tailored to Patient’s Individual Risk

“The results of our study show that tailoring the extent of radiotherapy according to how well the chemotherapy has worked to treat cancer in the lymph nodes leads to very low and reassuring recurrenc...

Share

  • 1

    10-year study on breast cancer recurrence post-chemotherapy and surgery.

  • 2

    Tailored radiotherapy reduces side effects.

  • 3

    24 out of 838 patients experienced recurrence (2.9%).

  • 4

    Low-risk patients can avoid radiotherapy entirely.

  • 5

    Study emphasizes personalized treatment approaches.

  • 6

    Future research will focus on tumor characteristics and recurrence factors.

  • 7

    Presented by Dr. Fleur Mauritz at EBCC15.

Original Source(s)

Breast Cancer Recurrence Remains Low—Even After 10 Years—With Radiotherapy Tailored to Patient’s Individual Risk

  • by The ASCO Post Staff

  • March 30, 2026

Related Content

New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes

Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery

These results come from the pilot phase of the phase III ADARNAT randomized international clinical trial, which is investigating whether axillary radiotherapy has a lower risk of lymphedema than axill...

Therapeutic Advances in Metastatic Melanoma: TILs, ImmTACs, and Targeted Therapies